Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Medical Care Ag ADR (FMS)

Fresenius Medical Care Ag ADR (FMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,867,884
  • Shares Outstanding, K 586,830
  • Annual Sales, $ 20,923 M
  • Annual Income, $ 582,080 K
  • EBIT $ 1,589 M
  • EBITDA $ 3,474 M
  • 60-Month Beta 0.87
  • Price/Sales 0.69
  • Price/Cash Flow 5.64
  • Price/Book 0.99

Options Overview Details

View History
  • Implied Volatility 52.42% ( -0.69%)
  • Historical Volatility 22.11%
  • IV Percentile 62%
  • IV Rank 51.50%
  • IV High 94.82% on 04/08/25
  • IV Low 7.41% on 10/08/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 19
  • Volume Avg (30-Day) 61
  • Put/Call OI Ratio 0.53
  • Today's Open Interest 1,416
  • Open Int (30-Day) 1,252

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 0.47
  • Number of Estimates 3
  • High Estimate 0.54
  • Low Estimate 0.41
  • Prior Year 0.38
  • Growth Rate Est. (year over year) +23.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.16 +3.36%
on 06/18/25
29.07 -6.98%
on 06/12/25
-1.35 (-4.76%)
since 06/11/25
3-Month
23.27 +16.18%
on 04/21/25
30.46 -11.23%
on 05/21/25
+3.06 (+12.76%)
since 04/11/25
52-Week
17.93 +50.81%
on 08/08/24
30.46 -11.23%
on 05/21/25
+7.20 (+36.29%)
since 07/11/24

Most Recent Stories

More News
Zacks.com featured highlights Fresenius Medical Care, Eldorado Gold, Hope Bancorp and Heritage Insurance

For Immediate ReleaseChicago, IL – July 8, 2025 – The stocks in this week’s article are Fresenius Medical Care AG & Co. FMS, Eldorado Gold EGO, Hope Bancorp Inc. HOPE and Heritage Insurance Holdings,...

HRTG : 21.08 (-1.22%)
EGO : 20.48 (+2.71%)
FMS : 27.04 (-1.49%)
HOPE : 11.50 (-1.12%)
4 High Earnings Yield Value Stocks You Should be Owning

The U.S. stock market bounced back from its April lows, ending the first half of the year on a strong note. Fears over the impact of tariffs somewhat eased, and a strong June jobs report helped ease concerns...

HRTG : 21.08 (-1.22%)
EGO : 20.48 (+2.71%)
FMS : 27.04 (-1.49%)
HOPE : 11.50 (-1.12%)
Is DaVita Stock Underperforming the S&P 500?

DaVita’s performance over the past year has fallen short of the broader S&P 500 Index, prompting a neutral outlook from analysts regarding its future prospects.

$SPX : 6,259.75 (-0.33%)
FMS : 27.04 (-1.49%)
DVA : 142.55 (-0.63%)
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?

With women’s health increasingly becoming a global priority, investors are actively targeting companies operating in this space to boost their portfolios. Research and Markets projects the women’s...

HOLX : 65.72 (-1.69%)
DGX : 168.09 (-1.96%)
RHHBY : 40.4900 (-1.77%)
FMS : 27.04 (-1.49%)
New Strong Buy Stocks for May 9th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Chain Bridge Bancorp, Inc. CBNA: This bank holding company for Chain Bridge Bank, N.A. has seen the Zacks Consensus Estimate for...

WYY : 3.07 (-4.06%)
BCRX : 8.76 (-1.35%)
BNTGY : 12.9400 (-4.43%)
FMS : 27.04 (-1.49%)
CBNA : 26.92 (-0.26%)
Best Income Stocks to Buy for May 9th

Here are two stocks with buy rank and strong income characteristics for investors to consider today, May 9th:Sumitomo Corporation SSUMY: This general trading company has witnessed the Zacks Consensus Estimate...

SSUMY : 25.2400 (-0.86%)
FMS : 27.04 (-1.49%)
Watch These 3 MedTech Stocks for Q1 Earnings: Beat or Miss?

The first-quarter 2025 earnings season is underway for the Medical sector (one of the 16 broad Zacks sectors within the Zacks Industry classification), with several MedTech companies already releasing...

MASI : 162.99 (-2.00%)
FMS : 27.04 (-1.49%)
CLOV : 2.92 (-4.26%)
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline

Glaukos Corporation GKOS reported first-quarter 2025 adjusted loss of 22 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 33 cents. The figure also improved from the...

MASI : 162.99 (-2.00%)
GKOS : 103.81 (-2.57%)
FMS : 27.04 (-1.49%)
AHCO : 9.22 (-2.43%)
ARAY Stock Down Despite Q3 Earnings Beat Estimates, Revenues Up Y/Y

Accuray Incorporated ARAY reported third-quarter fiscal 2025 loss per share of a cent compared with the year-ago period’s loss of 6 cents. The bottom line surpassed the Zacks Consensus Estimate by 80%.ARAY’s...

ARAY : 1.3600 (-3.55%)
MASI : 162.99 (-2.00%)
FMS : 27.04 (-1.49%)
AHCO : 9.22 (-2.43%)
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook

CONMED Corporation CNMD delivered first-quarter 2025 adjusted earnings per share (EPS) of 95 cents, which beat the Zacks Consensus Estimate of 81 cents by 17.3%. The bottom line improved 20.3% from the...

MASI : 162.99 (-2.00%)
CNMD : 51.27 (-4.29%)
FMS : 27.04 (-1.49%)
AHCO : 9.22 (-2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Fresenius Medical Care AG & Co. KGaA is one of the largest integrated providers of products and services for individuals undergoing dialysis. Fresenius Medical provides products and services across the entire dialysis value chain throughout the World. Fresenius Medical manufactures a variety of durable...

See More

Key Turning Points

3rd Resistance Point 27.42
2nd Resistance Point 27.28
1st Resistance Point 27.16
Last Price 27.04
1st Support Level 26.90
2nd Support Level 26.76
3rd Support Level 26.64

See More

52-Week High 30.46
Last Price 27.04
Fibonacci 61.8% 25.67
Fibonacci 50% 24.19
Fibonacci 38.2% 22.72
52-Week Low 17.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar